Could a Child's own cord blood stem cells restore hearing?

NCT ID NCT02038972

Completed Disease control Sponsor: James Baumgartner, MD Source: ClinicalTrials.gov ↗

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether infusing a child's own stored umbilical cord blood stem cells is safe for children with acquired sensorineural hearing loss. The trial enrolls children with moderate to profound hearing loss and aims to see if the infusion can improve inner ear function, hearing, and language development. It is an early-stage safety study involving 11 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous stem cells from cord blood
What this could lead to: If safe and effective, this approach could offer a way to improve inner ear function and language development in children with acquired hearing loss.
What could go wrong: This is a very early Phase 1 safety trial with only 11 children. It is not designed to prove the treatment works, and there is no guarantee of hearing improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORINEURAL HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder X-linked mixed hearing loss with perilymphatic gusher

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SENSORINEURAL HEARING LOSS

Contacts and locations

Show contact details

Locations

Florida Hospital

Orlando, Florida, 32803, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.